You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PVRL2

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma Trial (intensity-modulated radiotherapy (IMRT))

Not yet recruiting
  • Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
  • intensity-modulated radiotherapy (IMRT)
  • (no location specified)
Jun 4, 2023

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Boston, Massachusetts
  • +1 more
Aug 15, 2022

CNS Lymphoma Trial in Worldwide (GB5121)

Recruiting
  • CNS Lymphoma
  • Phoenix, Arizona
  • +5 more
Jul 26, 2022

Primary Vitreoretinal Lymphoma Trial in Beijing (Methotrexate, Rituximab, Zanubrutinib)

Recruiting
  • Primary Vitreoretinal Lymphoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 19, 2021

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, CNS Lymphoma, Intraocular

Completed
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
  • +5 more
  • Scottsdale, Arizona
  • +6 more
Jul 18, 2019